Q-omics provides the consensus-scored RNA5SP172 profile across patient tissues and cancer cell-line models. RNA5SP172 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in KIRP. Additionally, RNA5SP172 RNA expression shows 5,272 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRP, and STAD as cancer lineages where RNA5SP172 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.